Canyon Labs acquires iuvo BioScience’s lab, consulting services

Canyon Labs announced the strategic acquisition of iuvo BioScience’s laboratory services and scientific consulting divisions, according to a press release.

The acquisition “positions Canyon Labs to deliver comprehensive end-to-end solutions in pharmaceutical and medical device development and strengthens iuvo BioScience’s focus on transformative ophthalmic clinical development contract research,” the release said.

Iuvo BioScience will retain its clinical research team and leadership structure.

“This transaction marks a defining moment for iuvo,” Ben Burton, president and CEO of iuvo BioScience, said in the release. “This strategic decision reinforces our fundamental mission of accelerating patient access to breakthrough vision care treatments. By sharpening our focus on our ophthalmic clinical contract research business, we’re strengthening our ability to provide the high-touch, science-driven solutions our customers and partners have come to expect from iuvo.”

Published by:

Read more about

This post was originally published on this site